Lidija Latifovic, MSc

#cancer #raredisease #epi #rwe
she/her
Views are my own

[Lidija Latifovic, MSc @lidsinc]

Published in JAMA
Network, @tara_kiran et al. highlight how median annual payments change as the proportion of female physicians in a specialty increases https://t.co/tnPBMi0zqr

[Lidija Latifovic, MSc @lidsinc]

@EricTopol @NatureMed Yikes!

[Lidija Latifovic, MSc @lidsinc]

https://t.co/bbSpUpfjAd

@lejlalatifovic talks with @TVOKids1 about carbon sink forests! What a beautiful lab 🥹🤩!

[Lidija Latifovic, MSc @lidsinc]

I'm raising money in support of Baycrest - dementia research & care - by riding in the Bike for Brain Health. It is double your donation day! Mattamy Homes will double all donations $50-$500 today. Please consider donating today at https://t.co/Ysbw3CLcbb. #fearnoage

[Lidija Latifovic, MSc @lidsinc]

Circumstances under which a drug can be reassessed include (1) a high unmet need or (2) substantial uncertainty in the magnitude of the clinical benefit of the drug that can be feasibly addressed by a RWE study. #cholangiocarcinoma

[Lidija Latifovic, MSc @lidsinc]

Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of ... https://t.co/yFlWIdEGcA

[Sharlene Gill, MD, MPH, MBA, FASCO @GillSharlene]

🙏@ArndtVogel @auer_r @c3_cholangio
📌 FGFR2 fusions in cholangioCA are rare 💚
📌 FGFR- such as pemigatinib offer meaningful benefit - these pts have no other options 😞
📌 pemigatinib was approved by Health Canada in 9-21 but remains unfunded! @CADTH_ACMTS
📌 it IS funded in 🇺🇸 🇫🇷 🏴󠁧󠁢󠁥󠁮󠁧󠁿 🇯🇵 🇩🇪 🇮🇹 🇪🇸 ++
Time to step up 🇨🇦
@JustinTrudeau @markhollandlib @adriandix @curecc @CAMO_ACOM

[Lidija Latifovic, MSc @lidsinc]

@ArndtVogel @kristatee What is the best thing families and advocates can do to help this cause along?

[Arndt Vogel @ArndtVogel]

Apologies for the lengthy message, but this is really important to me.
We need to join forces to make targeted therapies a global success story in cholangiocarcinoma
🧐Here's what we need:
👉Cutting-edge & validated genetic testing
👉Better understanding of resistance mechanisms
👉Improved accessibility to testing & drugs
👉Overcoming global inadequacies in drug access, which presents a major issue here in 🇨🇦
🤔see an example of CADTH's stance on what continues to impede access to effective 🎯💊 for pts w/ FGFR2 fusions in Canada:
https://t.co/l7QY1jbtGx
🤨& my email to the Ontario Ministry of Health this morning👇
@myESMO @EASLnews @ILCAnews @curecc #livertwitter

[Lidija Latifovic, MSc @lidsinc]

Genetic testing practices among specialist physicians who treat prostate cancer: A Canadian, cross-sectional survey ... https://t.co/XvoS7xaJTG

[Lidija Latifovic, MSc @lidsinc]

Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada https://t.co/7c3lVJsN0M

[Lidija Latifovic, MSc @lidsinc]

Access to oncology pharmaceutical innovations in Canada. IQVIA White paper. https://t.co/YmtS1A5Ysk

[Lidija Latifovic, MSc @lidsinc]

@edwinkhoo You'll be a really fit doctor Ph by the end of your degree

[Lidija Latifovic, MSc @lidsinc]

Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs: a systematic review and meta-analysis | Future Oncology https://t.co/GLmbdxAm7K

[JAMA Network Open @JAMANetworkOpen]

Patients of physicians who used more virtual care did not have more ED visits. Virtual primary care is not driving ED use. https://t.co/KwtuSdXBRe @tara_kiran @RickGlazier1 @DrMichaelGreen1 et al. @UnityHealthTO @ICESOntario @MAP_Health @INSPIRE_PHC @UnityHealthTO @QueensuFamMed

[Dr Mike Green @DrMichaelGreen1]

Our latest paper on virtual care: patients of FPs who provided more virtual care were NOT more likely to go to the ED. @tara_kiran @RickGlazier1 https://t.co/cNfI0jdPMW via @JAMANetworkOpen part of @JAMANetwork

[Tara Kiran @tara_kiran]

In 2021, family docs were being blamed for seeing too many patients virtually, purportedly causing more people to visit the ED

Our latest research @JAMANetworkOpen @ICESOntario shows that simply was NOT true 🧵

w/ @RickGlazier1 @DrMichaelGreen1
https://t.co/WaMzT2HeuY

[Lidija Latifovic, MSc @lidsinc]

Virtual Care and ED Use Among Patients of Family Physicians https://t.co/6Fci3lKfJb via @JAMANetworkOpen part of @JAMANetwork

[Lidija Latifovic, MSc @lidsinc]

Burden of Acute-Care Hospitalization for Community-Acquired Pneumonia in Canadian Adults Aged 50 Years or Older: Focusing on Most Responsible Diagnosis Tells Only Part of the Story https://t.co/rDyyqwq9YR #mdpivaccines via @MDPIOpenAccess

[Lidija Latifovic, MSc @lidsinc]

Relational Continuity, Physician Payment, and Team-Based Primary Care in the Canadian Health Care System https://t.co/giBd9SmLh2